Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism
Craig Meagher(Western University), Terry L. Delovitch(Western University), Noah Horst(Boston University), Qing‐Sheng Mi(Henry Ford Health System), Wei Chen(University of Pittsburgh), William W. Cruikshank(Boston University), Josh Beilke(University of California, San Francisco), Guillermo Arreaza(Robarts Clinical Trials), Konstantin V. Salojin(Robarts Clinical Trials)
Cited by 44
Related Papers
Seven new loci associated with age-related macular degeneration
|Nature Genetics|2013|802
Immunoglobulin Activation of T Cell Chemoattractant Expression in Fibroblasts from Patients with Graves’ Disease Is Mediated Through the Insulin-Like Growth Factor I Receptor Pathway
|The Journal of Immunology|2003|294
Interleukin-16
|Journal of Leukocyte Biology|2000|277
Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression.
|Proceedings of the National Academy of Sciences|1994|270
Interleukin 16 and its function as a CD4 ligand
|Immunology Today|1996|255